An experimental objective method to determine maximum output and dynamic range of an active bone conduction implant: the Bonebridge.

Otol Neurotol

*University Department of Otorhinolaryngology, Head and Neck Surgery, Antwerp University Hospital; †Faculty of Medicine, Antwerp University, Belgium; ‡Hearing and Implants, Department of Otorhinolaryngology, Radboud University Nijmegen Medical Centre; and §Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.

Published: August 2014

Introduction: Recently, a new active bone conduction implant, the Bonebridge, was introduced. This transcutaneous device is proposed as an alternative to previous percutaneous systems. The current study aims to determine the maximum output (MO) of the Bonebridge by making use of Bonebridge-generated sound pressure levels in the occluded ear canal of the unaided ear.

Methodology: The test setup consisted of audiometry and input-output measurements. These tests were performed on 3 Bonebridge users with conductive or mixed hearing loss (bone-conduction thresholds, ≤ 45 dB HL) at least 3 months after implantation surgery. All the patients were implanted and were evaluated in the Antwerp University Hospital. The MO of the device was determined by measuring input-output functions with a microphone placed in the occluded contralateral ear canal using the Aurical REM system. During testing, the sound processor was fitted in linear amplification mode and with unlimited output to determine the MO and the input dynamic range of the Bonebridge. This experimental setup intends to evaluate the device in a fitting program without compression.

Results: The mean MO of the device was 55 dB HL (SD, 6 dB HL) at 0.5 kHz, 61 dB HL (SD, 18 dB HL), 71 dB HL (SD, 10 dB HL) at 2 kHz, and 60 dB HL (SD, 10 dB HL) at 4 kHz. The mean dynamic range of the Bonebridge was 41 (SD, 5) dB HL, 46 (SD, 10) dB HL, 46 (SD, 5) dB HL, and 37 (SD, 16) dB HL for 0.5, 1, 2, and 4 kHz, respectively.

Conclusion: In summary, ear canal measures can effectively be used to assess input-output behavior of the Bonebridge. The present study indicates that the MO of the Bonebridge ranges from 55 to 71 dB HL, depending on frequency. Accepting a minimum dynamic range of 35 dB with the Bonebridge, fitting of the Bonebridge in a linear program is advocated in patients with a sensorineural hearing loss component of up to 30 dB HL.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0000000000000347DOI Listing

Publication Analysis

Top Keywords

dynamic range
16
ear canal
12
range bonebridge
12
bonebridge
10
determine maximum
8
maximum output
8
active bone
8
bone conduction
8
conduction implant
8
implant bonebridge
8

Similar Publications

Background: The global pandemic caused by SARS-CoV-2 has resulted in millions of people experiencing long COVID condition, a range of persistent symptoms following the acute phase, with an estimated prevalence of 27%-64%.

Materials And Methods: To understand its pathophysiology, we conducted a longitudinal study on viral load and cytokine dynamics in individuals with confirmed SARS-CoV-2 infection. We used reverse transcriptase droplet digital PCR to quantify viral RNA from nasopharyngeal swabs and employed multiplex technology to measure plasma cytokine levels in a cohort of people with SARS-CoV-2 infection.

View Article and Find Full Text PDF

A Highly Sensitive Creatine Kinase Detection in Human Serum using 11-mercaptoundecanoic acid Modified ITO-PET Electrodes.

Anal Biochem

January 2025

Çanakkale Onsekiz Mart University, Faculty of Engineering, Bioengineering Department, Çanakkale-TURKEY. Electronic address:

The enzyme creatine kinase (CK) is a biomarker that plays an extremely significant role in the early detection of cardiovascular disorders. Serum levels of CK are regularly monitored in patients with heart attacks, one of the most critical cardiovascular illnesses. In this study, a highly sensitive electrochemical immunosensor system was designed for the importance of early diagnosis of CK.

View Article and Find Full Text PDF

Reversible light-responsive protein hydrogel for on-demand cell encapsulation and release.

Acta Biomater

January 2025

Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, TX, 78712, USA. Electronic address:

The design of biomaterials that can reconfigure on-demand in response to external stimuli is an emerging area in materials research. However, achieving reversible assembly of protein-based biomaterials by light input remains a major challenge. Here, we present the engineering of a new protein material that is capable of switching between liquid and solid state reversibly, controlled by lights of different wavelengths.

View Article and Find Full Text PDF

Prevalence and impact of parental co-morbid anxiety and depression during the first 2 years postpartum in China.

J Affect Disord

January 2025

Department of Developmental and Behavioral Pediatrics, National Children's Medical Center, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Pediatric Translational Medicine Institute, National Children's Medical Center, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Center for Brain Science and Brain-Inspired Technology, Shanghai, China. Electronic address:

Background: Parental postpartum co-morbid anxiety and depression negatively impact personal well-being, family dynamics, and child developmental outcomes. This study investigates the prevalence of co-morbid anxiety and depression in both mothers and fathers during the first 2 years postpartum in China, and to explore its associations with parental family support, maternal health-related quality of life (HRQoL), and child development.

Methods: This cross-sectional study was conducted in China, involving families with children aged 0-2 years who participated in community child health care.

View Article and Find Full Text PDF

The current study focuses on the potential of second-generation antihistamines, which exhibit fewer side effects compared to first-generation drugs, to block the Histamine H receptor (HR) and mitigate allergic responses. We screened several derivatives of second-generation drugs taking Desloratadine (Deslo) and Acrivastine (Acra) as seed compounds. We performed molecular docking, drug-likeness, quantum chemical calculations, UV-visible and infrared spectroscopy, molecular electrostatic potential (MEP) mapping for understanding drug derivatives potential as efficient drugs and molecular dynamics (MD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!